CS

Chandra Sekhar Chivukula

Active Director Director DIN 07578103
DIN 07578103 First appointment Aug 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 14 active board seats
Past companies 3 historical roles
Total affiliations 17 Since Aug 2016
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 03 Aug 2016
Active appointments 15
Total timeline records 17

Chandra Sekhar Chivukula (DIN 07578103) has 17 recorded board appointments in Indian companies, the first from August 2016, of which 15 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2016
Medvital Healthcare India Private Limited Director · 2025 – present
Current
Star Fertility Private Limited Director · 2024 – present
Current
Current
Mikata Industries And Tech Services Llp Partner · 2023 – present
Current
Stemcyte India Therapeutics Private Limited Director · 2021 – present
Current
Apollo Dialysis Private Limited Director · 2021 – present
Current
Alliance Dental Care Limited Director · 2021 – present
Current
Apollo Fertility Centre Private Limited Director · 2020 – present
Current
Apollo Specialty Hospitals Private Limited Director · 2018 – present
Current
Apollo Bangalore Cradle Limited Director · 2018 – present
Current
Ahll Diagnostics Limited Director · 2018 – present
Current
Apollo Spectra Centres Private Limited Director · 2018 – present
Current
Apollo Sugar Clinics Limited Director · 2018 – present
Current
Family Health Plan Insurance Tpa Limited Director · 2016 – present
Current
Previous
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available